Finzelberg introduces CONCENTAL, a new botanical ingredient for cognitive health
The new plant-based stimulant promotes brain health for high-stress situations.
Image © AdobeStock.com/PIC4U
Finzelberg (Andernach, Germany), producer of more than 80 botanical extracts for pharmaceuticals and dietary supplements, announced in an August 2, 2024 news release its new ingredient, CONCENTAL. Designed for supporting brain health, the non-stimulant ingredient helps cerebral blood flow and affects serotonin, noradrenaline, and dopamine. The presence of phenolic acids found in Sideritis plant species contribute to the potential positive cognitive effects of CONCENTAL.
These effects are reportedly supported by Finzelberg’s pre-clinical research. “From our proprietary clinical trial data we can see significant beneficial effects on the ability to process information while increasing mental flexibility and memory,” explains Dr. René Roth-Ehrang, Member of the Management Board Development and Quality at Finzelberg, in the news release.
CONCENTAL can be used in various formats – capsules, gummies, powders, and more – and as either a standalone ingredient or added to product formulas. It is also designed for various age groups, for coping with everyday stressors, protecting cognition in older adults, or enhancing mental acuity for athletes.
Finzelberg will be present at the upcoming Vitafoods Asia and SupplySide West tradeshows.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
